List of Covagen patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9790475 Human serum albumin binding compounds and fusion proteins thereof	Patent 9790475 was granted and assigned to Covagen on October, 2017 by the United States Patent and Trademark Office.	Covagen	Covagen	United States Patent and Trademark Office	9790475	October 17, 2017
‌ US Patent 9593314 Binding molecules with antitumoral activity	Patent 9593314 was granted and assigned to Covagen on March, 2017 by the United States Patent and Trademark Office.	Covagen	Covagen	United States Patent and Trademark Office	9593314	March 14, 2017
‌ US Patent 10364419 Human serum albumin binding compounds and fusion proteins thereof	Patent 10364419 was granted and assigned to Covagen on July, 2019 by the United States Patent and Trademark Office.	Covagen	Covagen	United States Patent and Trademark Office	10364419	July 30, 2019
‌ US Patent 9315557 IL-17A binding molecules and medical uses thereof	Patent 9315557 was granted and assigned to Covagen on April, 2016 by the United States Patent and Trademark Office.	Covagen	Covagen	United States Patent and Trademark Office	9315557	April 19, 2016
‌ US Patent 9376477 IL-17 binding compounds and medical uses thereof	Patent 9376477 was granted and assigned to Covagen on June, 2016 by the United States Patent and Trademark Office.		Covagen	United States Patent and Trademark Office	9376477	June 28, 2016
‌ US Patent 10722589 FGFR3 binding molecules	Patent 10722589 was granted and assigned to Covagen on July, 2020 by the United States Patent and Trademark Office.	Covagen	Covagen	United States Patent and Trademark Office	10722589	July 28, 2020
‌ US Patent 9085760 Chymase binding compounds and medical uses thereof	Patent 9085760 was granted and assigned to Covagen on July, 2015 by the United States Patent and Trademark Office.		Covagen	United States Patent and Trademark Office	9085760	July 21, 2015